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Abstract Tyrosine-based motifs are involved in both protein 
targeting and, via SH2 domain binding, intracellular signalling. 
To date there has only been one example of such a motif acting 
as both an intracellular sorting signal and SH2 binding 
determinant, namely that of the T cell costimulation receptor, 
CTLA-4. We show that insulin stimulation of cultured rat 
hepatoma cells results in increased cell surface expression of 
TGN38. Furthermore, the cytosolic domain of TGN38 can be 
phosphorylated by the insulin receptor in vitro and tyrosine 
phosphorylated TGN38 can specifically bind to the SH2 domains 
of the spleen tyrosine kinase Syk. These data imply that tyrosine-
based motifs may play a broader role than has previously been 
accepted and could help to integrate trafficking and signalling 
events. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Tyrosine-based targeting signals conforming to the consen-
sus, -YXX0- (where 0 indicates a hydrophobic amino acid), 
mediate a number of intracellular protein sorting events in-
cluding endocytosis and lysosomal targeting [1,2]. Internalisa-
tion at the cell surface is mediated by interaction of these 
motifs with the μ2 subunit of the clathrin adaptor complex, 
AP2 [2]. These sequences are remarkably similar to phospho-
tyrosine-based motifs that direct SH2 (Src-homology 2) do-
main binding [3,4]. SH2 domains are globular protein do-
mains of approximately 100 amino acids that mediate a 
number of intracellular signalling processes via interaction 
with specific phosphotyrosine motifs. Despite both targeting 
and SH2 binding being critical events within eukaryotic cells, 
there have, until recently, been no examples of -YXX0- mo-
tifs acting as both a subcellular targeting motif and, when 
phosphorylated, an SH2 binding determinant. During the 
preparation of this article, Shiratori et al. [5] published data 
showing that the motif -YVKM- within the cytosolic domain 
of the T cell costimulatory molecule, CTLA-4, was capable of 
interacting with both μ2 and, when phosphorylated, the tyro-
sine phosphatase Syp [5]. 
TGN38 is a type I integral membrane protein that cycles 
between the trans-Golgi network (TGN) and plasma mem-
brane [6]. The sequence -SDYQRL- (amino acids 331-336) 
within the cytosolic domain of TGN38 has previously been 
shown to be required for efficient internalisation from the cell 
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surface and targeting back to the TGN (reviewed in [7]). This 
motif has been employed by a number of groups to study the 
function of tyrosine based sorting determinants (e.g. [8-10]). 
TGN38 is very efficiently internalised from the plasma mem-
brane [7] and the cytosolic domain of the protein has been 
shown to interact with the μ2 subunit of the AP2 clathrin 
adaptor complex [9,10]. Binding experiments using synthetic 
peptides have shown that phosphorylation of the tyrosine res-
idue within the -SDYQRL- motif significantly reduces binding 
of TGN38 to μ2. However, tyrosine phosphorylation of 
TGN38 has never been demonstrated. 
We have found that insulin simulation of cultured cells 
results in an increase in the amount of TGN38 at the cell 
surface. The cytosolic domain of TGN38 can also be phos-
phorylated in vitro by an enriched preparation of the insulin 
receptor tyrosine kinase. Furthermore, we show that tyrosine 
phosphorylated TGN38 can specifically bind to the SH2 do-
mains of the spleen tyrosine kinase Syk [11]. This represents a 
further demonstration of the potential regulation of both traf-
ficking and intracellular signalling through the phosphoryla-
tion and dephosphorylation of a single tyrosine residue. 
2. Materials and methods 
2.1. Flow cytometry 
H4-II-E cells were serum starved for 2 h before stimulation for 
5 min with 100 nM insulin. Cells were then washed 3 times in ice 
cold PBS and removed from dishes with 5 mM EDTA. All subsequent 
steps were performed at 4°C. Cells were incubated for 20 min in 
PBS+2% fetal calf serum before staining with either 2F7.1 (anti-
TGN38 [12], Affinity Bioreagents, Inc.) or an isotype-matched nega-
tive control antibody (Serotec) followed by biotinylated anti-mouse 
antibody and streptavidin-phycoerythrin (Serotec). Cells were washed 
in 4 ml of PBS+2% FCS between layers. Flow cytometry was per-
formed on a Becton-Dickinson FACSCalibur with CellQuest soft-
ware. 
2.2. In vitro phosphorylation 
Thioredoxin-TGN38 fusion proteins [9] were phosphorylated as 
described in [13] with [γ-32Ρ]ΑΤΡ (ICN). Briefly, insulin receptor 
was purified by affinity chromatography on wheat germ agglutinin 
sepharose [18], preactivated by incubation at 4°C in the presence of 
insulin and unlabelled ATP. Recombinant proteins were then phos-
phorylated by incubation for 30 min at 30°C in the presence of 
[γ-32Ρ]ΑΤΡ. Phosphorylation reactions were separated by SDS-
PAGE on 15% gels. Dried gels were imaged using a Molecular Dy-
namics phosphorimager. 
2.3. SH2 domain binding 
GST fusion proteins corresponding to the SH2 domains of Syk, 
Shb, Shp-1, p85 and PLCy were expressed in Escherichia coli accord-
ing to standard protocols and, following cell lysis, bound to gluta-
thione agarose (Pharmacia). Immobilised GST fusion proteins were 
subsequently incubated for 2 h at room temperature with 32P-labelled 
TGN38 cytosolic domain, washed five times in phosphate buffered 
saline, pH 7.4, separated by SDS-PAGE, dried and imaged. 
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3. Results and discussion 
We initially observed using flow cytometry that insulin 
stimulation of the cultured rat hepatoma cell line, H4-II-E, 
results in an increase in the amount of TGN38 at the cell 
surface (Fig. 1). Following stimulation of cells with 100 nM 
insulin, the mean increase in the mean fluorescence intensity 
was found to be 3.5 units (S.E. ±1.2 units). Increased cell 
surface expression following insulin stimulation has also 
been observed for a number of other proteins including the 
bifunctional mannose-6-phosphate/insulin-like growth factor 
receptor (M6PR/IGFIIR [14]) and the insulin responsive glu-
cose transporter, GLUT4 [15]. These proteins, like TGN38, 
cycle between intracellular compartments and the cell surface 
[15,16]. It is possible that insulin stimulation results in active 
translocation of TGN38 to the plasma membrane as is seen 
for GLUT4 [15]. Alternatively, internalisation of the protein 
from the plasma membrane may be impaired. Given the in-
trinsic tyrosine kinase activity of the insulin receptor [17], the 
latter explanation would appear to be the most probable since 
interaction of TGN38 with the endocytic machinery (namely 
the μ2 subunit of the plasma membrane clathrin adaptor com-
plex, AP2 [8-10] is blocked by phosphorylation of the 
-SDYQRL- motif [8]. 
In order to investigate the phosphorylation of TGN38 di-
rectly, insulin receptors were partially purified by wheat germ 
agglutinin affinity chromatography from CHO.T cells [18]. 
This preparation was found to be capable of the in vitro 
phosphorylation of the cytosolic domain of TGN38 expressed 
as a thioredoxin fusion protein (Fig. 2). Phosphorylation was 
shown to be specific to tyrosine-333 of TGN38 since mutation 
of this residue to alanine abolished the effect (Fig. 2A). Fur-
thermore, the phosphorylated TGN38 fusion protein was 
shown to be recognised in immunoblot analysis with the phos-
photyrosine-specific monoclonal antibody, 4G10. Phospho-
amino acid analysis confirmed phosphorylation of tyrosine-
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Fig. 1. Effect of insulin stimulation on cell surface TGN38. Cells 
were serum starved for 2 h before stimulation for 5 min with 100 
nM insulin. Cells were then stained for flow cytometry at 4°C. The 
dotted line indicates staining with the negative control antibody, the 
dashed line indicates staining with 2F7.1 (anti-TGN38) without in-
sulin treatment, the solid line indicates staining with 2F7.1 following 
insulin stimulation. 
Fig. 2. In vitro phosphorylation of the cytosolic domain of TGN38. 
A: Phosphorylation of wild-type TGN38 (WT) and Y333A mutant 
(Y333A). B: Insulin responsiveness of in vitro phosphorylation. 
333 (not shown). This in vitro phosphorylation event was 
also shown to be insulin responsive (Fig. 2B). These results, 
in conjunction with those from cultured cells, suggest that the 
insulin receptor may be capable of phosphorylating TGN38 
directly resulting in an increase in TGN38 at the cell surface. 
However, we cannot exclude the involvement of an intermedi-
ate kinase which is activated by, and co-purifies with, the 
insulin receptor. 
Thus the internalisation motif, -SDYQRL-, can be phos-
phorylated in response to insulin stimulation. Such tyrosine 
based internalisation motifs (conforming to the consensus 
-YXX0-, where 0 indicates a hydrophobic amino acid) are 
strikingly similar to phosphotyrosine motifs involved in SH2 
domain binding [4]. SH2 domains are globular protein do-
mains of approximately 100 amino acids that mediate protein 
tyrosine kinase signalling by binding directly to phosphotyr-
osine motifs [3]. 
Given that we had shown tyrosine phosphorylation of the 
consensus internalisation motif of TGN38 and that this motif 
also conforms to the generic SH2 domain binding motif, we 
decided to test binding of tyrosine phosphorylated TGN38 to 
a number of SH2 domains. Consensus binding motifs of a 
number of SH2 domains have been determined using degen-
erate phosphopeptide libraries and other similar approaches 
[4]. We tested binding of several SH2 domains to TGN38, 
many of which have previously been shown to bind preferen-
tially to pYXXL sequences [4]. Tyrosine phosphorylated 
TGN38 was found to bind specifically to the tandem SH2 
domains of the spleen tyrosine kinase Syk [19] (Fig. ЗА) which 
is indeed selective for pYXXL motifs. No binding was de-
tected to the SH2 domains of phospholipase Cy [20], protein 
tyrosine phosphatase 1 [21], the adaptor protein Shb [22] or 
the p85 subunit of phosphatidylinositol-3 kinase [23] (Fig. 
ЗА). Binding occurred to both individual SH2 domains of 
Syk with some selectivity for the carboxy-terminal domain 
(Fig. 3B, lanes 3 and 4). This is in concurrence with previously 
published data since the predicted phosphopeptide motif for 
interaction with the C-terminal SH2 domain of Syk (pY-(Q/T/ 
E)-(E/Q/T)-L [4]) has more similarity to the sequence of 
TGN38 (-pY-Q-R-L) than that of the N-terminal SH2 do-
main of Syk (which preferentially binds to the sequence, 
pY-T-T-(I/L/M) [4]). 
It should be noted that the insulin receptor [24], Syk [11] 
and TGN38 (Stephens and Banting, unpublished results) are 
all present in the cells of at least one tissue (spleen). This 
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ponents of tyrosine kinase signalling pathways, but also as 
potential sites for the integration and parallel regulation of 
both trafficking and signalling pathways. 
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Fig. 3. Binding of SH2 domains to tyrosine phosphorylated 
TGN38. Immobilised SH2 domains were then incubated with in vi-
tro phosphorylated TGN38 as Fig. 2. A: Binding to GST-SH2 do-
mains. Lane 1, GST; lane 2, Shb; lane 3, Syk; lane 4, p85; lane 5, 
Shp-1; lane 6, PLCy. B: Binding to the tandem (T), N-terminal (N) 
and C-terminal (C) SH2 domains of Syk. 
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